Lesson 1.1: Beyond the A1C Number
Introduction
You got your lab results. Your doctor circled the A1C number—maybe 5.8%, maybe 6.2%—and said the words: "You have prediabetes." Perhaps they handed you a pamphlet about eating less sugar and losing weight.
What they probably didn't explain is what that number actually means, why it's an incomplete picture of your metabolic health, and why focusing solely on A1C may cause you to miss the real problem until it's much harder to fix.
What A1C Actually Measures
Hemoglobin A1C (HbA1c) measures the percentage of your red blood cells that have glucose attached to them. Because red blood cells live approximately 90-120 days, A1C provides a rough average of your blood sugar over the past 2-3 months.
The standard ranges are:
- Normal: Below 5.7%
- Prediabetes: 5.7% to 6.4%
- Diabetes: 6.5% or higher
This seems straightforward. Higher average blood sugar = higher A1C = worse metabolic health. But the reality is more nuanced.
The Limitations of A1C
1. It's a Lagging Indicator
A1C only rises after your blood sugar has been elevated for extended periods. But here's what most people don't realize: blood sugar is one of the last things to become dysregulated in metabolic disease.
Your body fights hard to keep blood glucose in a narrow range because high blood sugar is immediately toxic to tissues. It does this by producing more and more insulin. For years—sometimes decades—your pancreas compensates by pumping out extra insulin to force glucose into resistant cells.
During this compensation phase, your A1C looks normal. You pass your annual physical. You're told you're "fine."
But you're not fine. You're developing insulin resistance, and your pancreas is working overtime. By the time A1C rises into the prediabetic range, you've likely been insulin resistant for 10-15 years.
A study in Diabetes Care followed individuals for up to 13 years before diabetes diagnosis and found that insulin resistance and beta-cell dysfunction were present long before glucose levels became abnormal. Tabak et al., 2009 PMID: 19587363
2. It Doesn't Show Glucose Variability
A1C is an average. Two people can have the same A1C of 5.9% with completely different glucose patterns:
- Person A: Stable glucose between 90-110 mg/dL all day
- Person B: Swings from 70 to 180 mg/dL after meals, averaging out to the same number
Person B has significant metabolic dysfunction—their post-meal glucose spikes are damaging blood vessels and triggering inflammation—but their A1C doesn't reveal this.
Research shows that glucose variability, independent of average glucose, is associated with increased cardiovascular risk and oxidative stress. Ceriello et al., 2008 PMID: 18268044
3. A1C Can Be Inaccurate for Many People
Several factors affect A1C accuracy:
- Anemia or conditions affecting red blood cell turnover can falsely lower or raise A1C
- Hemoglobin variants (common in certain ethnicities) can interfere with some testing methods
- Kidney disease and liver disease affect A1C accuracy
- Recent blood loss or transfusion skews results
A study found that A1C may underestimate average glucose in African Americans compared to whites, potentially delaying diagnosis. Herman et al., 2007 PMID: 17327340
The Glucose-Insulin Disconnect
Here's the key insight that changes everything: glucose and insulin tell different stories.
Imagine your cells as houses with locks (insulin receptors) and insulin as the key. In a healthy metabolism, insulin arrives, unlocks the door, and glucose enters the cell to be used for energy.
In insulin resistance, the locks become rusty. The key still works, but you need to jiggle it harder. Your pancreas responds by making more keys (more insulin). For a while, this works—glucose still gets into cells, and blood sugar stays normal.
But you're now hyperinsulinemic—you have chronically elevated insulin levels. This causes its own cascade of problems:
- Increased fat storage, especially visceral (belly) fat
- Increased hunger and cravings
- Elevated triglycerides
- Higher blood pressure
- Inflammation
- Accelerated aging
All of this happens while your A1C remains in the "normal" range.
A landmark study found that fasting insulin levels predicted the development of type 2 diabetes up to 24 years before diagnosis, while glucose remained normal. Dankner et al., 2009 PMID: 19223598
Why This Matters for You
If you've been diagnosed with prediabetes based on A1C:
-
You're not catching this early—you're catching it late. Your body has likely been compensating for years.
-
There's still time to reverse it. Prediabetes means your pancreas is still producing enough insulin to partially compensate. Once beta cells burn out, reversal becomes much harder.
-
You need better data. A1C alone doesn't tell you how insulin resistant you are or how hard your pancreas is working.
Key Takeaways
- A1C measures average blood sugar over 2-3 months
- It's a lagging indicator—insulin resistance develops years before A1C rises
- A1C doesn't reveal glucose variability or insulin levels
- Hyperinsulinemia (high insulin) causes metabolic damage while glucose appears "normal"
- Prediabetes diagnosis means you've been insulin resistant for years, but reversal is still possible
References
-
Tabak AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimaki M, Witte DR. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet. 2009;373(9682):2215-2221. PubMed PMID: 19515410
-
Ceriello A, Esposito K, Piconi L, et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes. 2008;57(5):1349-1354. PubMed PMID: 18268044
-
Herman WH, Ma Y, Uwaifo G, et al. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care. 2007;30(10):2453-2457. PubMed PMID: 17536077
-
Dankner R, Chetrit A, Shanik MH, Raz I, Roth J. Basal state hyperinsulinemia in healthy normoglycemic adults heralds dysglycemia after more than two decades of follow up. Diabetes Metab Res Rev. 2009;25(3):219-223. PubMed PMID: 19223598